APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dasatinib Generics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dasatinib Generics Industry Growth and Trends Forecast to 2032

27 December 202590 pages

Choose your research edition.

Industry ResearchDasatinib Generics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dasatinib Generics Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Dasatinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dasatinib Generics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dasatinib Generics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dasatinib Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dasatinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dasatinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dasatinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dasatinib Generics include Bristol Myers Squibb, Lupin, Sawai Pharmaceutical, XSpray Pharma, Qilu Pharmaceutical, CSPC Ouyi Pharmaceutical and Chia Tai Tianqing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dasatinib Generics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dasatinib Generics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dasatinib Generics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dasatinib Generics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dasatinib Generics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dasatinib Generics Market by Company

Bristol Myers Squibb

Lupin

Sawai Pharmaceutical

XSpray Pharma

Qilu Pharmaceutical

CSPC Ouyi Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Dasatinib Generics Segment by Type

80mg per Tablet

70mg per Tablet

50mg per Tablet

20mg per Tablet

140mg per Tablet

100mg per Tablet

Dasatinib Generics Segment by Application

Acute Lymphocytic Leukemia

Chronic Myeloid Leukemia

Dasatinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dasatinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dasatinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dasatinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dasatinib Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dasatinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 80mg per Tablet Table 2. Major Company of 70mg per Tablet Table 3. Major Company of 50mg per Tablet Table 4. Major Company of 20mg per Tablet Table 5. Major Company of 140mg per Tablet Table 6. Major Company of 100mg per Tablet Table 7. Global Dasatinib Generics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Dasatinib Generics Sales by Type (2021-2026) & (K Units) Table 9. Global Dasatinib Generics Sales Market Share in Volume by Type (2021-2026) Table 10. Global Dasatinib Generics Sales by Type (2021-2026) & (US$ Million) Table 11. Global Dasatinib Generics Sales Market Share in Value by Type (2021-2026) Table 12. Global Dasatinib Generics Price by Type (2021-2026) & (US$/Unit) Table 13. Global Dasatinib Generics Sales by Type (2027-2032) & (K Units) Table 14. Global Dasatinib Generics Sales Market Share in Volume by Type (2027-2032) Table 15. Global Dasatinib Generics Sales by Type (2027-2032) & (US$ Million) Table 16. Global Dasatinib Generics Sales Market Share in Value by Type (2027-2032) Table 17. Global Dasatinib Generics Price by Type (2027-2032) & (US$/Unit) Table 18. North America Dasatinib Generics Sales by Type (2021-2026) & (K Units) Table 19. North America Dasatinib Generics Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Dasatinib Generics Sales by Type (2021-2026) & (K Units) Table 21. Europe Dasatinib Generics Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Dasatinib Generics Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Dasatinib Generics Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Dasatinib Generics Sales by Type (2021-2026) & (K Units) Table 25. Latin America Dasatinib Generics Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Dasatinib Generics Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Dasatinib Generics Sales by Type (2021-2026) & (US$ Million) Table 28. Dasatinib Generics Industry Trends Table 29. Dasatinib Generics Industry Drivers Table 30. Dasatinib Generics Industry Opportunities and Challenges Table 31. Dasatinib Generics Industry Restraints Table 32. Global Dasatinib Generics Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Dasatinib Generics Revenue Market Share by Company (2021-2026) Table 34. Global Dasatinib Generics Sales by Company (2021-2026) & (K Units) Table 35. Global Dasatinib Generics Sales Share by Company (2021-2026) Table 36. Global Dasatinib Generics Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Dasatinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Dasatinib Generics Major Company Production Sites and Headquarters Table 39. Global Dasatinib Generics Company, Product Type & Application Table 40. Global Dasatinib Generics Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Dasatinib Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Dasatinib Generics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Dasatinib Generics Sales by Region (2021-2026) & (K Units) Table 45. Global Dasatinib Generics Sales Market Share in Volume by Region (2021-2026) Table 46. Global Dasatinib Generics Sales by Region (2021-2026) & (US$ Million) Table 47. Global Dasatinib Generics Sales Market Share in Value by Region (2021-2026) Table 48. Global Dasatinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Dasatinib Generics Sales by Region (2027-2032) & (K Units) Table 50. Global Dasatinib Generics Sales Market Share in Volume by Region (2027-2032) Table 51. Global Dasatinib Generics Sales by Region (2027-2032) & (US$ Million) Table 52. Global Dasatinib Generics Sales Market Share in Value by Region (2027-2032) Table 53. Global Dasatinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Dasatinib Generics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Dasatinib Generics Sales by Application (2021-2026) & (K Units) Table 56. Global Dasatinib Generics Sales Market Share in Volume by Application (2021-2026) Table 57. Global Dasatinib Generics Sales by Application (2021-2026) & (US$ Million) Table 58. Global Dasatinib Generics Sales Market Share in Value by Application (2021-2026) Table 59. Global Dasatinib Generics Price by Application (2021-2026) & (US$/Unit) Table 60. Global Dasatinib Generics Sales by Application (2027-2032) & (K Units) Table 61. Global Dasatinib Generics Sales Market Share in Volume by Application (2027-2032) Table 62. Global Dasatinib Generics Sales by Application (2027-2032) & (US$ Million) Table 63. Global Dasatinib Generics Sales Market Share in Value by Application (2027-2032) Table 64. Global Dasatinib Generics Price by Application (2027-2032) & (US$/Unit) Table 65. North America Dasatinib Generics Sales by Application (2021-2026) & (K Units) Table 66. North America Dasatinib Generics Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Dasatinib Generics Sales by Application (2021-2026) & (K Units) Table 68. Europe Dasatinib Generics Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Dasatinib Generics Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Dasatinib Generics Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Dasatinib Generics Sales by Application (2021-2026) & (K Units) Table 72. Latin America Dasatinib Generics Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Dasatinib Generics Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Dasatinib Generics Sales by Application (2021-2026) & (US$ Million) Table 75. Bristol Myers Squibb Company Information Table 76. Bristol Myers Squibb Business Overview Table 77. Bristol Myers Squibb Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Bristol Myers Squibb Dasatinib Generics Product Portfolio Table 79. Bristol Myers Squibb Recent Development Table 80. Lupin Company Information Table 81. Lupin Business Overview Table 82. Lupin Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Lupin Dasatinib Generics Product Portfolio Table 84. Lupin Recent Development Table 85. Sawai Pharmaceutical Company Information Table 86. Sawai Pharmaceutical Business Overview Table 87. Sawai Pharmaceutical Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Sawai Pharmaceutical Dasatinib Generics Product Portfolio Table 89. Sawai Pharmaceutical Recent Development Table 90. XSpray Pharma Company Information Table 91. XSpray Pharma Business Overview Table 92. XSpray Pharma Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. XSpray Pharma Dasatinib Generics Product Portfolio Table 94. XSpray Pharma Recent Development Table 95. Qilu Pharmaceutical Company Information Table 96. Qilu Pharmaceutical Business Overview Table 97. Qilu Pharmaceutical Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Qilu Pharmaceutical Dasatinib Generics Product Portfolio Table 99. Qilu Pharmaceutical Recent Development Table 100. CSPC Ouyi Pharmaceutical Company Information Table 101. CSPC Ouyi Pharmaceutical Business Overview Table 102. CSPC Ouyi Pharmaceutical Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. CSPC Ouyi Pharmaceutical Dasatinib Generics Product Portfolio Table 104. CSPC Ouyi Pharmaceutical Recent Development Table 105. Chia Tai Tianqing Pharmaceutical Company Information Table 106. Chia Tai Tianqing Pharmaceutical Business Overview Table 107. Chia Tai Tianqing Pharmaceutical Dasatinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Chia Tai Tianqing Pharmaceutical Dasatinib Generics Product Portfolio Table 109. Chia Tai Tianqing Pharmaceutical Recent Development Table 110. North America Dasatinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 111. North America Dasatinib Generics Sales by Country (2021-2026) & (K Units) Table 112. North America Dasatinib Generics Sales Market Share by Country (2021-2026) Table 113. North America Dasatinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 114. North America Dasatinib Generics Sales Market Share Forecast by Country (2027-2032) Table 115. North America Dasatinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. North America Dasatinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 117. North America Dasatinib Generics Market Share by Country (2021-2026) Table 118. North America Dasatinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. North America Dasatinib Generics Market Share Forecast by Country (2027-2032) Table 120. Europe Dasatinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. Europe Dasatinib Generics Sales by Country (2021-2026) & (K Units) Table 122. Europe Dasatinib Generics Sales Market Share by Country (2021-2026) Table 123. Europe Dasatinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 124. Europe Dasatinib Generics Sales Market Share Forecast by Country (2027-2032) Table 125. Europe Dasatinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Europe Dasatinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 127. Europe Dasatinib Generics Market Share by Country (2021-2026) Table 128. Europe Dasatinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Europe Dasatinib Generics Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Dasatinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Dasatinib Generics Sales by Country (2021-2026) & (K Units) Table 132. Asia-Pacific Dasatinib Generics Sales Market Share by Country (2021-2026) Table 133. Asia-Pacific Dasatinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 134. Asia-Pacific Dasatinib Generics Sales Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Dasatinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Dasatinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 137. Asia-Pacific Dasatinib Generics Market Share by Country (2021-2026) Table 138. Asia-Pacific Dasatinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Asia-Pacific Dasatinib Generics Market Share Forecast by Country (2027-2032) Table 140. Latin America Dasatinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 141. Latin America Dasatinib Generics Sales by Country (2021-2026) & (K Units) Table 142. Latin America Dasatinib Generics Sales Market Share by Country (2021-2026) Table 143. Latin America Dasatinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 144. Latin America Dasatinib Generics Sales Market Share Forecast by Country (2027-2032) Table 145. Latin America Dasatinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Latin America Dasatinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 147. Latin America Dasatinib Generics Market Share by Country (2021-2026) Table 148. Latin America Dasatinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Latin America Dasatinib Generics Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Dasatinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Dasatinib Generics Sales by Country (2021-2026) & (K Units) Table 152. Middle East and Africa Dasatinib Generics Sales Market Share by Country (2021-2026) Table 153. Middle East and Africa Dasatinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 154. Middle East and Africa Dasatinib Generics Sales Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Dasatinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Dasatinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 157. Middle East and Africa Dasatinib Generics Market Share by Country (2021-2026) Table 158. Middle East and Africa Dasatinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Middle East and Africa Dasatinib Generics Market Share Forecast by Country (2027-2032) Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Dasatinib Generics Distributors List Table 163. Dasatinib Generics Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Dasatinib Generics Image Figure 2. Global Dasatinib Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dasatinib Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Dasatinib Generics Sales (2021-2032) & (K Units) Figure 5. 80mg per Tablet Image Figure 6. Global 80mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 70mg per Tablet Image Figure 8. Global 70mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 50mg per Tablet Image Figure 10. Global 50mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. 20mg per Tablet Image Figure 12. Global 20mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 13. 140mg per Tablet Image Figure 14. Global 140mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 15. 100mg per Tablet Image Figure 16. Global 100mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Dasatinib Generics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Dasatinib Generics Market Share by Type 2025 VS 2032 Figure 19. North America Dasatinib Generics Sales Market Share in Volume by Type in 2025 Figure 20. North America Dasatinib Generics Sales Market Share in Value by Type in 2025 Figure 21. Europe Dasatinib Generics Sales Market Share in Volume by Type in 2025 Figure 22. Europe Dasatinib Generics Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Dasatinib Generics Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Dasatinib Generics Sales Market Share in Value by Type in 2025 Figure 25. Latin America Dasatinib Generics Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Dasatinib Generics Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Dasatinib Generics Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Dasatinib Generics Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Dasatinib Generics Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Acute Lymphocytic Leukemia Image Figure 32. Global Acute Lymphocytic Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 33. Chronic Myeloid Leukemia Image Figure 34. Global Chronic Myeloid Leukemia Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Dasatinib Generics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Dasatinib Generics Market Share by Application 2025 VS 2032 Figure 37. North America Dasatinib Generics Sales Market Share in Volume by Application in 2025 Figure 38. North America Dasatinib Generics Sales Market Share in Value by Application in 2025 Figure 39. Europe Dasatinib Generics Sales Market Share in Volume by Application in 2025 Figure 40. Europe Dasatinib Generics Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Dasatinib Generics Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Dasatinib Generics Sales Market Share in Value by Application in 2025 Figure 43. Latin America Dasatinib Generics Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Dasatinib Generics Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Dasatinib Generics Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Dasatinib Generics Sales Market Share in Value by Application in 2025 Figure 47. North America Dasatinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Dasatinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Dasatinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Dasatinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Dasatinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Dasatinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Dasatinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Dasatinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Dasatinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Dasatinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Dasatinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Dasatinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Dasatinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Dasatinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Dasatinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Dasatinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Dasatinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Dasatinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Dasatinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Dasatinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Dasatinib Generics Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Dasatinib Generics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg per Tablet
  • 70mg per Tablet
  • 50mg per Tablet
  • 20mg per Tablet
  • 140mg per Tablet
  • 100mg per Tablet
Applications
  • Acute Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
Companies covered
  • Bristol Myers Squibb
  • Lupin
  • Sawai Pharmaceutical
  • XSpray Pharma
  • Qilu Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dasatinib Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dasatinib Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dasatinib Generics Market by Type
  6. 1.3.1 80mg per Tablet
  7. 1.3.2 70mg per Tablet
  8. 1.3.3 50mg per Tablet
  9. 1.3.4 20mg per Tablet
  10. 1.3.5 140mg per Tablet
  11. 1.3.6 100mg per Tablet
  12. 1.4 Global Dasatinib Generics Market Size by Type
  13. 1.4.1 Global Dasatinib Generics Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Dasatinib Generics Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Dasatinib Generics Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Dasatinib Generics Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Dasatinib Generics Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Dasatinib Generics Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Dasatinib Generics Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Dasatinib Generics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dasatinib Generics Industry Trends
  2. 2.2 Dasatinib Generics Industry Drivers
  3. 2.3 Dasatinib Generics Industry Opportunities and Challenges
  4. 2.4 Dasatinib Generics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dasatinib Generics Revenue (2021-2026)
  2. 3.2 Global Top Players by Dasatinib Generics Sales (2021-2026)
  3. 3.3 Global Top Players by Dasatinib Generics Price (2021-2026)
  4. 3.4 Global Dasatinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dasatinib Generics Major Company Production Sites & Headquarters
  6. 3.6 Global Dasatinib Generics Company, Product Type & Application
  7. 3.7 Global Dasatinib Generics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dasatinib Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dasatinib Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dasatinib Generics Tier 1, Tier 2, and Tier 3
4 Dasatinib Generics Regional Status and Outlook
  1. 4.1 Global Dasatinib Generics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dasatinib Generics Historic Market Size by Region
  3. 4.2.1 Global Dasatinib Generics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dasatinib Generics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dasatinib Generics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dasatinib Generics Forecasted Market Size by Region
  7. 4.3.1 Global Dasatinib Generics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dasatinib Generics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dasatinib Generics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dasatinib Generics by Application
  1. 5.1 Dasatinib Generics Market by Application
  2. 5.1.1 Acute Lymphocytic Leukemia
  3. 5.1.2 Chronic Myeloid Leukemia
  4. 5.2 Global Dasatinib Generics Market Size by Application
  5. 5.2.1 Global Dasatinib Generics Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dasatinib Generics Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dasatinib Generics Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dasatinib Generics Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dasatinib Generics Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dasatinib Generics Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dasatinib Generics Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dasatinib Generics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol Myers Squibb
  2. 6.1.1 Bristol Myers Squibb Company Information
  3. 6.1.2 Bristol Myers Squibb Business Overview
  4. 6.1.3 Bristol Myers Squibb Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol Myers Squibb Dasatinib Generics Product Portfolio
  6. 6.1.5 Bristol Myers Squibb Recent Developments
  7. 6.2 Lupin
  8. 6.2.1 Lupin Company Information
  9. 6.2.2 Lupin Business Overview
  10. 6.2.3 Lupin Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lupin Dasatinib Generics Product Portfolio
  12. 6.2.5 Lupin Recent Developments
  13. 6.3 Sawai Pharmaceutical
  14. 6.3.1 Sawai Pharmaceutical Company Information
  15. 6.3.2 Sawai Pharmaceutical Business Overview
  16. 6.3.3 Sawai Pharmaceutical Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sawai Pharmaceutical Dasatinib Generics Product Portfolio
  18. 6.3.5 Sawai Pharmaceutical Recent Developments
  19. 6.4 XSpray Pharma
  20. 6.4.1 XSpray Pharma Company Information
  21. 6.4.2 XSpray Pharma Business Overview
  22. 6.4.3 XSpray Pharma Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 XSpray Pharma Dasatinib Generics Product Portfolio
  24. 6.4.5 XSpray Pharma Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Dasatinib Generics Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 CSPC Ouyi Pharmaceutical
  32. 6.6.1 CSPC Ouyi Pharmaceutical Company Information
  33. 6.6.2 CSPC Ouyi Pharmaceutical Business Overview
  34. 6.6.3 CSPC Ouyi Pharmaceutical Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSPC Ouyi Pharmaceutical Dasatinib Generics Product Portfolio
  36. 6.6.5 CSPC Ouyi Pharmaceutical Recent Developments
  37. 6.7 Chia Tai Tianqing Pharmaceutical
  38. 6.7.1 Chia Tai Tianqing Pharmaceutical Company Information
  39. 6.7.2 Chia Tai Tianqing Pharmaceutical Business Overview
  40. 6.7.3 Chia Tai Tianqing Pharmaceutical Dasatinib Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chia Tai Tianqing Pharmaceutical Dasatinib Generics Product Portfolio
  42. 6.7.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Dasatinib Generics Sales by Country
  2. 7.1.1 North America Dasatinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dasatinib Generics Sales by Country (2021-2026)
  4. 7.1.3 North America Dasatinib Generics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dasatinib Generics Market Size by Country
  6. 7.2.1 North America Dasatinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dasatinib Generics Market Size by Country (2021-2026)
  8. 7.2.3 North America Dasatinib Generics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dasatinib Generics Sales by Country
  2. 8.1.1 Europe Dasatinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dasatinib Generics Sales by Country (2021-2026)
  4. 8.1.3 Europe Dasatinib Generics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dasatinib Generics Market Size by Country
  6. 8.2.1 Europe Dasatinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dasatinib Generics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dasatinib Generics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dasatinib Generics Sales by Country
  2. 9.1.1 Asia-Pacific Dasatinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dasatinib Generics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dasatinib Generics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dasatinib Generics Market Size by Country
  6. 9.2.1 Asia-Pacific Dasatinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dasatinib Generics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dasatinib Generics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dasatinib Generics Sales by Country
  2. 10.1.1 South America Dasatinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dasatinib Generics Sales by Country (2021-2026)
  4. 10.1.3 South America Dasatinib Generics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dasatinib Generics Market Size by Country
  6. 10.2.1 South America Dasatinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dasatinib Generics Market Size by Country (2021-2026)
  8. 10.2.3 South America Dasatinib Generics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dasatinib Generics Sales by Country
  2. 11.1.1 Middle East and Africa Dasatinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dasatinib Generics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dasatinib Generics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dasatinib Generics Market Size by Country
  6. 11.2.1 Middle East and Africa Dasatinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dasatinib Generics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dasatinib Generics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dasatinib Generics Value Chain Analysis
  2. 12.1.1 Dasatinib Generics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dasatinib Generics Production Mode & Process
  7. 12.2 Dasatinib Generics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dasatinib Generics Distributors
  10. 12.2.3 Dasatinib Generics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst